These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Use of methotrexate in spondylarthropathies. Review of the literature]. Toussirot E; Wendling D Rev Med Interne; 1996; 17(4):333-9. PubMed ID: 8761799 [TBL] [Abstract][Full Text] [Related]
26. Disease-modifying antirheumatic drug therapy for spondyloarthropathies: advances in treatment. Mease PJ Curr Opin Rheumatol; 2003 May; 15(3):205-12. PubMed ID: 12707572 [TBL] [Abstract][Full Text] [Related]
27. Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset. Olivieri I; Salvarani C; Cantini F; Ciancio G; Padula A Curr Opin Rheumatol; 2001 Jul; 13(4):280-4. PubMed ID: 11555728 [TBL] [Abstract][Full Text] [Related]
28. Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis. Fleischmann R; Iqbal I Drugs Aging; 2007; 24(3):239-54. PubMed ID: 17362051 [TBL] [Abstract][Full Text] [Related]
34. Retrospective study of juvenile spondylarthropathies in Croatia over the last 11 years. Prutki M; Tambic Bukovac L; Jelusic M; Potocki K; Kralik M; Malcic I Clin Exp Rheumatol; 2008; 26(4):693-9. PubMed ID: 18799108 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Poddubnyy D; Rudwaleit M Expert Opin Drug Saf; 2011 Jul; 10(4):655-73. PubMed ID: 21554150 [TBL] [Abstract][Full Text] [Related]
36. [Follow-up of the patient with spondyloarthropathy]. Dougados M Ann Med Interne (Paris); 1998 Apr; 149(3):149-55. PubMed ID: 11490537 [TBL] [Abstract][Full Text] [Related]
37. Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up. Huerta-Sil G; Casasola-Vargas JC; Londoño JD; Rivas-Ruíz R; Chávez J; Pacheco-Tena C; Cardiel MH; Vargas-Alarcón G; Burgos-Vargas R Ann Rheum Dis; 2006 May; 65(5):642-6. PubMed ID: 16219705 [TBL] [Abstract][Full Text] [Related]
38. Skeletal indicators of reactive arthritis: A case study comparison to other skeletal conditions, such as rheumatoid arthritis, ankylosing spondylitis, ankylosing sero-negative SpA, and DISH. Cawley WD; Paine RR Int J Paleopathol; 2015 Dec; 11():70-74. PubMed ID: 28802971 [TBL] [Abstract][Full Text] [Related]
39. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH Arthritis Res Ther; 2017 May; 19(1):102. PubMed ID: 28521824 [TBL] [Abstract][Full Text] [Related]
40. Ankylosing spondylitis in a military aviator: air medical considerations. Eslami R; Momenzadeh M; Ebadi A Air Med J; 2014; 33(3):115-7. PubMed ID: 24787516 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]